Speed regulatory compliance with continuous publishing

Life science organisations are increasingly focusing on how they can improve the speed and efficiency of their operations

picture of

Breaking News

Elligo Health Research acquires Protenium Clinical Research

Protenium conducts pharmaceutical studies in a broad range of therapeutic areas

Surge in cell and gene therapy trials highlight the UK’s leading position as developmental hub in this innovative industry

Global industry shows confidence in cell and gene therapies and in UK’s ability to deliver these life-changing ...

Clinical trial launches to develop breath test for multiple cancers

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the ...

Innovation in clinical trials

Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, ...

Almac invites attendees to a San Diego workshop to learn about cold chain management in clinical trials

Almac Clinical Services is pleased to invite participants from the pharmaceutical and biopharma industries to join its ...

Pfizer’s palbociclib is the top breast cancer drug used in clinical trials initiated in 2018

Breast cancer is the most commonly diagnosed cancer in women and is the fifth largest cause of cancer mortality ...

Advanced Clinical announces new office location at Partnerships in Clinical Trials Europe

Advanced Clinical is a global clinical development organisation that provides CRO, FSP, quality and validation, and ...

PCI Clinical Services to showcase expertise in Phase I clinical trials in Australia

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to ...

Keeping trials on track

If a clinical trial is to remain on schedule and within its planned study close out timeline, then trial supplies must ...

Clinical evaluation: three actions for improved medical device trials and compliance

The way we plan and conduct clinical investigations for medical devices must be adjusted to 21st century standards

Asceneuron initiates neuroimaging trial for tau modifier ASN120290

Major milestone in development of novel treatment for progressive supranuclear palsy and other tau-related dementias

Mirati Therapeutics joins Cancer Research UK's Stratified Medicine Programme

Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme, bringing new ...